PANCREATIC CANCER, ADULT

This study tests a new combination of four drugs (adebrelimab, chidamide, gemcitabine, and S1) as a first treatment for people with advanced or metastatic pancreatic cancer that cannot be removed by surgery. The goal is to see if this mix can slow tumor growth and extend survival…

This study tests whether a special protein drink (Peptamen 1.6) helps malnourished pancreatic cancer patients recover better after surgery compared to a standard high-protein drink. Twenty adults who are malnourished or at risk will receive both drinks at different times to see w…

This study looks at how the genetic makeup of pancreatic cancer affects response to FOLFIRINOX chemotherapy given before surgery. About 45 adults with non-metastatic pancreatic cancer will receive chemo, then have their tumors analyzed. The goal is to see if certain tumor types r…

This study tests a new blood test called Avantect to see if it can find pancreatic cancer early in people aged 50-84 who were diagnosed with type 2 diabetes in the last 6 months. About 15,000 participants will give blood samples and fill out anxiety questionnaires over a year. Th…

This study is screening adults who are at high risk for pancreatic cancer to find early signs of the disease. Researchers will use standard guidelines to identify and treat high-risk lesions before they become advanced cancer. The goal is to improve early detection and outcomes f…

This study is testing a new blood test that looks for tiny particles called exosomes to find pancreatic cancer early. The goal is to see if this test can accurately detect the disease in 2000 adults, including those with and without cancer. If successful, it could lead to a simpl…

This study tests whether a specially trained community health worker can improve symptoms and quality of life for people newly diagnosed with pancreatic cancer, and also help their caregivers. About 60 patients and their caregivers will be randomly assigned to either work with a …

This study is developing a blood test that uses artificial intelligence to spot cancer early and see how well treatments are working. Researchers will analyze blood samples from 6000 adults with or without cancer to find unique signals in platelets and immune cells. The goal is a…

This pilot study tests whether a structured program of exercise, nutrition, and symptom management (called prehabilitation) can be used by adults with pancreatic cancer while they receive chemotherapy before planned surgery. The study will enroll 20 participants to see if the pro…